Data as of Sep 18
| -0.14 / -1.05%|
The 2 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 15.25, with a high estimate of 23.50 and a low estimate of 7.00. The median estimate represents a +15.97% increase from the last price of 13.15.
The current consensus among 2 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.